Objectives

After participating in this educational activity, attendees should be able to:
1. Describe the roles of the members of the health care team in their respective responsibilities for quality care.
2. Discuss some basic pharmacological concepts regarding ketamine including mechanism of action, metabolism, dosing, duration, and potential adverse effects.
3. Describe situations to use ketamine as a main induction agent versus as a adjuvant.
4. Describe the uses of ketamine in chronic pain setting.
5. Describe the use of ketamine in patients with depression.
6. 
Describe the limitations that still exist our understanding of ketamine and potential areas for further study.

Faculty

Swati Choudhary, MD
Pain Fellow
University of Massachusetts Medical School-Baystate
Physician
Baystate Medical Center 

Faculty Disclosure

The design and content of Baystate Continuing Interprofessional Education ( CE ) activities support quality improvement in healthcare and provide fair and balanced views of therapeutic options.  Faculty or planner conflicts of interest are resolved before the educational activity.

None of the members of the faculty and planning committee for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.

                                                                           

Session date: 
Thursday, March 4, 2021 - 7:00am to 8:00am
Location: 
Baystate Medical Center
759 Chestnut Street
WebEx
Springfield, MA 01199
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 BCIPE Instructional Hours

Please login or register to take this course.